Grants per year
Personal profile
Research Interests
Daniel Batlle MD is the Earle, del Greco, Levin Professor of Medicine at Northwestern University. He has been a Professor of Medicine at Northwestern and past Division Chief for 18 years . His clinical and research interests include acid-base disturbances, electrolyte disorders, hypertension, and diabetic nephropathy. Bench research currently involves the study of the renin angiotensin system and enzymes that degrade angiotensin 2 such as ACE2 and its potential therapeutic use.
Certifications and Licenses
| Internal Medicine | |
| Nephrology |
Training Experience
| 1976 | Internship, Saint John Hospital and Medical Center, Detroit, Michigan |
| 1977 | Residency, Wayne State University |
| 1979 | Fellowship, Univ. of Illinois Hospital |
Education/Academic qualification
MD, University of Barcelona
… → 1973
Research interests
- Hypertension
- Kidney
- Nephrology
Fingerprint Dive into the research topics where Daniel Batlle is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 15 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
The Role of MicroRNAs in Corneal Epithelial Homeostasis
Batlle, D., Lavker, R. M., Peng, H. & Thaxton, C. S.
Kennedy Institute - National Eye Clinic
7/1/19 → 7/31/23
Project: Research project
Prot #16244: A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multicenter, Event-Driven Phase III Study to Investigate the Efficacy and Safety of Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Subjects
Batlle, D., Molitch, M. E. & Wallia, A.
Bayer HealthCare Pharmaceuticals, Inc.
1/5/16 → 5/31/20
Project: Research project
Urinary Renin Angiotensin System in Diabetes
Batlle, D., Molitch, M. E., Rademaker, A. W. & Wysocki, J.
National Institute of Diabetes, Digestive and Kidney Diseases
6/15/15 → 4/30/20
Project: Research project
Prot #BAY 94-8862/16243: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY-94-8862 in Subjects with Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropa
Batlle, D., Molitch, M. E. & Wallia, A.
Bayer HealthCare Pharmaceuticals, Inc.
1/2/14 → 1/2/17
Project: Research project
Research Output
Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent
Serfozo, P., Wysocki, J., Gulua, G., Schulze, A., Ye, M., Liu, P., Jin, J., Bader, M., Myöhänen, T., García-Horsman, J. A. & Batlle, D., Jan 1 2020, In : Hypertension (Dallas, Tex. : 1979). 75, 1, p. 173-182 10 p.Research output: Contribution to journal › Article
Angiotensin-(1-7) for diabetic kidney disease: better than an angiotensin-converting enzyme inhibitor alone?
Marquez, A. & Batlle, D., Oct 1 2019, In : Kidney international. 96, 4, p. 815-817 3 p.Research output: Contribution to journal › Comment/debate
Novel variants of angiotensin converting enzyme-2 of shorter molecular size to target the kidney renin angiotensin system
Wysocki, J., Schulze, A. & Batlle, D., Dec 2019, In : Biomolecules. 9, 12, 886.Research output: Contribution to journal › Article
Open Access
Progressive hypertension and severe left ventricular outflow tract obstruction
Cameron, A. C., Lang, N. N., Dominiczak, A. F., Jennings, G. L. R., Batlle, D., Bursztyn, M., Chugh, A. R., Floras, J. S., Taler, S. J., Touyz, R. M. & Delles, C., Dec 1 2019, In : Hypertension. 74, 6, p. 1216-1225 10 p.Research output: Contribution to journal › Article
Proximal renal tubular acidosis with and without fanconi syndrome
Kashoor, I. & Batlle, D., Sep 2019, In : Kidney Research and Clinical Practice. 38, 3, p. 267-281 15 p.Research output: Contribution to journal › Review article
Open Access